argenex SE (ARGX) vs Moderna, Inc. (MRNA)

• argenex SE ARGX 909.66 ▲ +1.66%
• Moderna, Inc. MRNA 264.15 ▲ +9.40%

argenex SE and Moderna, Inc. are both Biotechnology companies. Moderna, Inc. is the larger, with a market value of $96.4B against $56.3B — 1.7× the size. Moderna, Inc. has negative trailing earnings, so its P/E is not meaningful; argenex SE trades at 29.8×. argenex SE grew revenue faster over the last twelve months: 60.8% against −27.6%. argenex SE has the higher net margin (31.7% vs −141.4%) and the higher return on invested capital (0.00% vs −93.5%). Across the 18 metrics below, argenex SE leads on 18 and Moderna, Inc. on 0.